Aarhus University Seal

Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Standard

Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures. / Nielsen, Søren Bang; Macchi, Francesca; Raccosta, Samuele et al.

In: P L o S One, Vol. 8, No. 7, e67713, 2013.

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

Harvard

Nielsen, SB, Macchi, F, Raccosta, S, Langkilde, AE, Giehm, L, Kyrsting, A, Svane, ASP, Manno, M, Christiansen, G, Nielsen, NC, Oddershede, L, Vestergaard, B & Otzen, D 2013, 'Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures', P L o S One, vol. 8, no. 7, e67713. https://doi.org/10.1371/journal.pone.0067713

APA

Nielsen, S. B., Macchi, F., Raccosta, S., Langkilde, A. E., Giehm, L., Kyrsting, A., Svane, A. S. P., Manno, M., Christiansen, G., Nielsen, N. C., Oddershede, L., Vestergaard, B., & Otzen, D. (2013). Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures. P L o S One, 8(7), [e67713]. https://doi.org/10.1371/journal.pone.0067713

CBE

Nielsen SB, Macchi F, Raccosta S, Langkilde AE, Giehm L, Kyrsting A, Svane ASP, Manno M, Christiansen G, Nielsen NC, et al. 2013. Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures. P L o S One. 8(7):Article e67713. https://doi.org/10.1371/journal.pone.0067713

MLA

Vancouver

Nielsen SB, Macchi F, Raccosta S, Langkilde AE, Giehm L, Kyrsting A et al. Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures. P L o S One. 2013;8(7):e67713. doi: 10.1371/journal.pone.0067713

Author

Nielsen, Søren Bang ; Macchi, Francesca ; Raccosta, Samuele et al. / Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures. In: P L o S One. 2013 ; Vol. 8, No. 7.

Bibtex

@article{c5fb018592eb43139b12a73155210cb5,
title = "Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures",
abstract = "Parkinson's Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein α-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onset familial PD and shows different aggregation behavior compared to wt aSN. Here we use a multidisciplinary approach to compare the aggregation process of wt and A30P aSN. In agreement with previous studies, we observe an initial lag phase followed by a continuous structural development of fibrils until reaching an apparent monomer-aggregate equilibrium state and a plateau in Thioflavin T (ThT) fluorescence intensity. However, at later timepoints A30P shows greater propensity than αSN wt to form dense bundled fibril networks. Combining small angle x-ray scattering, x-ray fibre diffraction and linear dichroism, we demonstrate that while the microscopic structure of the individual fibril essentially remains constant throughout the experiment, the formation of dense A30P fibril networks occur through a continuous assembly pathway while the formation of less dense wt fibril networks with fewer contact points follows a continuous path during the elongation phase and a second rearrangement phase after reaching the ThT fluorescence plateau. Our work thus highlights that structural rearrangements proceed beyond the plateau in ThT-based monitoring of the fibrillation process, and the density and morphology of the resulting fibril networks is highly dependent on the aSN form studied.",
author = "Nielsen, {S{\o}ren Bang} and Francesca Macchi and Samuele Raccosta and Langkilde, {Annette Eva} and Lise Giehm and Anders Kyrsting and Svane, {Anna Sigrid Pii} and Mauro Manno and Gunna Christiansen and Nielsen, {Niels Christian} and Lene Oddershede and Bente Vestergaard and Daniel Otzen",
year = "2013",
doi = "10.1371/journal.pone.0067713",
language = "English",
volume = "8",
journal = "P L o S One",
issn = "1932-6203",
publisher = "public library of science",
number = "7",

}

RIS

TY - JOUR

T1 - Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures

AU - Nielsen, Søren Bang

AU - Macchi, Francesca

AU - Raccosta, Samuele

AU - Langkilde, Annette Eva

AU - Giehm, Lise

AU - Kyrsting, Anders

AU - Svane, Anna Sigrid Pii

AU - Manno, Mauro

AU - Christiansen, Gunna

AU - Nielsen, Niels Christian

AU - Oddershede, Lene

AU - Vestergaard, Bente

AU - Otzen, Daniel

PY - 2013

Y1 - 2013

N2 - Parkinson's Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein α-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onset familial PD and shows different aggregation behavior compared to wt aSN. Here we use a multidisciplinary approach to compare the aggregation process of wt and A30P aSN. In agreement with previous studies, we observe an initial lag phase followed by a continuous structural development of fibrils until reaching an apparent monomer-aggregate equilibrium state and a plateau in Thioflavin T (ThT) fluorescence intensity. However, at later timepoints A30P shows greater propensity than αSN wt to form dense bundled fibril networks. Combining small angle x-ray scattering, x-ray fibre diffraction and linear dichroism, we demonstrate that while the microscopic structure of the individual fibril essentially remains constant throughout the experiment, the formation of dense A30P fibril networks occur through a continuous assembly pathway while the formation of less dense wt fibril networks with fewer contact points follows a continuous path during the elongation phase and a second rearrangement phase after reaching the ThT fluorescence plateau. Our work thus highlights that structural rearrangements proceed beyond the plateau in ThT-based monitoring of the fibrillation process, and the density and morphology of the resulting fibril networks is highly dependent on the aSN form studied.

AB - Parkinson's Disease (PD) is a neurodegenerative movement disorder affecting millions of people worldwide. One of the key players in the development of the disease is the protein α-synuclein (aSN), which aggregates in the brain of PD patients. The aSN mutant A30P has been reported to cause early-onset familial PD and shows different aggregation behavior compared to wt aSN. Here we use a multidisciplinary approach to compare the aggregation process of wt and A30P aSN. In agreement with previous studies, we observe an initial lag phase followed by a continuous structural development of fibrils until reaching an apparent monomer-aggregate equilibrium state and a plateau in Thioflavin T (ThT) fluorescence intensity. However, at later timepoints A30P shows greater propensity than αSN wt to form dense bundled fibril networks. Combining small angle x-ray scattering, x-ray fibre diffraction and linear dichroism, we demonstrate that while the microscopic structure of the individual fibril essentially remains constant throughout the experiment, the formation of dense A30P fibril networks occur through a continuous assembly pathway while the formation of less dense wt fibril networks with fewer contact points follows a continuous path during the elongation phase and a second rearrangement phase after reaching the ThT fluorescence plateau. Our work thus highlights that structural rearrangements proceed beyond the plateau in ThT-based monitoring of the fibrillation process, and the density and morphology of the resulting fibril networks is highly dependent on the aSN form studied.

U2 - 10.1371/journal.pone.0067713

DO - 10.1371/journal.pone.0067713

M3 - Journal article

C2 - 23861789

VL - 8

JO - P L o S One

JF - P L o S One

SN - 1932-6203

IS - 7

M1 - e67713

ER -